Results 281 to 290 of about 1,152,447 (302)

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

Lancet, The, 2003
Stefan D Anker, Salim Yusuf, Andrew Coats   +2 more
exaly  

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Lancet, The, 2006
Gilles R Dagenais, Janice Pogue, Salim Yusuf   +2 more
exaly  

Endogenous enzymes and enzyme inhibitors

2023
Christophe M. Courtin, Najwa Shufia Choliq, Mariette Bernard, Axelle Görtz, Gitte Devriese   +4 more
openaire   +1 more source

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Enzyme Inhibitors

2018
openaire   +1 more source

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

Enzyme Inhibitors.

Annals of Internal Medicine, 1981
openaire   +1 more source

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

Lancet, The, 2006
exaly  

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

Lancet, The, 2002
Koon K Teo, Salim Yusuf, Alistair Hall
exaly  

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Lancet, The, 1998
exaly